Semax

Semax is a short synthetic peptide related to ACTH, developed in Russia and used there in clinical settings including stroke care. Its published literature is small, largely regional, and rarely independently replicated. It is not approved in the United States or European Union, and evidence for cognitive enhancement in healthy adults is weak.

Educational content only - not medical advice. In a crisis, call or text 988 (US) or your local emergency number. See crisis resources.